fashion -WSS

fashion

author：focus 2025-09-27 15:35:28 - browse：4

Palm Drive at Stanford University on March 28, 2023 — Palm Drive at the entrance to Stanford University. Brian Frank for STAT

The resignation of Marc Tessier-Lavigne as president of Stanford University following an investigation into irregularities in his past research marks more than just the startling downfall of the leader of one of the nation’s top research powerhouses. The case is likely to have broader repercussions, signaling a tipping point in an ongoing and often contentious debate about how to assign blame and credit in the increasingly collaborative world of research.

Science is a team sport. And while the lab leaders, or principal investigators, often get most of the attention for biomedical breakthroughs, they seldom run experiments. That work is left to postdoctoral researchers, graduate students, and others who peer through microscopes, labor away in mouse rooms, and spend countless hours pipetting. Instead, professors play more of a managerial role, supervising, critiquing, and offering big-picture feedback on the work that goes on in their lab.

It’s a longstanding arrangement, but one that leads to a thorny question when research is challenged: Who’s to blame? STAT put that question to Stanford faculty and students while reporting earlier this year on allegations of image manipulation and other misconduct related to research in Tessier-Lavigne’s lab, as well as researchers at other institutions. The answer varied depending on whom you asked.

Graduate students stressed that since faculty have no qualms using work done in their labs to land grants, win prizes, and build prestige, they should ultimately be accountable for problems with the science done under their supervision. Faculty generally agree, at least in principle, but are often quick to say that there are limits to how closely they can scrutinize their lab’s work, and that team science is in part based on trust. It’s an argument Tessier-Lavigne cited in his own statement about his resignation.

It’s also one he said wasn’t good enough.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Wegovy, Zepbound and weight loss drugs that preserve muscle

Wikipedia

focus

WSS

Female surgeons have lower rates of long

Wegovy, Zepbound and weight loss drugs that preserve muscle

Wegovy, Zepbound and weight loss drugs that preserve muscle

There’s no way to know how good AI health technologies are

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Peter Marks talks Operation Warp Speed for Rare Diseases

Wikipedia

fashion

focus

At least 13 dead in Texas as scorching temps continue

How clinical AI models' predictive power can degrade over time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Humana CEO Bruce Broussard to step down in 2024

Medicare proposal to cover medical devices draws a mixed reaction

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

State Dept. review finds Biden bears some blame for Afghanistan failures

Humana CEO Bruce Broussard to step down in 2024

23andMe had bad news about my health. I wish a person had delivered it

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Wikipedia

What the Wegovy shortage looks like for doctors — and for patients

Readout LOUD podcast: A CRISPR milestone, biotech mixology

A revolution in caring for preterm infants

Readout LOUD podcast: Merger Mondays, Ozempic panic

Poor hospice wound care hurts patients and families

A revolution in caring for preterm infants

explore

Wikipedia

focus

Wikipedia